Bode is a member of the board of directors of Glytec and an active member of the JDRF research team validating the efficacy and safety of real-time continuous glucose monitoring (CGMS), and is a former president of the ADA Georgia Affiliate and editor of the ADA's 2004 edition of Medical Management of Type 1 Diabetes.
[1] Bode received his medical degree from Emory University School of Medicine in Atlanta, GA and completed a fellowship in diabetes with Paul C. Davidson, MD, and an internship and residency at Emory University Affiliated Hospitals.
Bode has co-authored many publications on the subject of inpatient glucose control and was a co-developer of the Glucommander software,[2] a computer-directed intravenous insulin system manufactured by Glytec, LLC.
[3] The Glucommander is intended to evaluate the current as well as cumulative patient blood glucose values, and, based on the aggregate of those measurements, whether one or many, regulate the infusion of I.V.
infusion pump, and drive the blood glucose level towards a predetermined target range.